SPPI: The flip side of Fri evening. SPPI has a scheduled Q1 call Monday 1:00PM EST, but slipped the numbers out in a 10Q w/o a PR. The strange thing is they seam quite good to me. They actually made a slight profit with 12M sales (9 Fusilev and 3 Zevilin). With sound balance sheet, running break even, 2-3 likely label expansions coming, and a partnered drug in P3 things look bright. But why hide it in a Fri evening 10Q? Perhaps the run-up in PPS to $4 was more than just pre-FDA hype. Huh wallstrb?